A leukemic plasmacytoid dendritic cell line, PMDC05, with the ability to secrete IFN-α by stimulation via Toll-like receptors and present antigens to naïve T cells-Reference-Cited by-同舟云学术

A leukemic plasmacytoid dendritic cell line, PMDC05, with the ability to secrete IFN-α by stimulation via Toll-like receptors and present antigens to naïve T cells

Published:2009-09 Issue:9 Volume:33 Page:1224-1232
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Narita Miwako,Watanabe Norihiro,Yamahira Akie,Hashimoto Shigeo,Tochiki Nozomi,Saitoh Anri,Kaji Masami,Nakamura Takeshi,Furukawa Tatsuo,Toba Ken,Fuse Ichiro,Aizawa Yoshifusa,Takahashi Masuhiro

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference38 articles.

1. From plasmacytoid to dendritic cell: morphological and functional switches during plasmacytoid pre-dendritic cell differentiation;Soumelis;Eur J Immunol,2006

2. Acute agranular CD4-positive natural killer cell leukemia. Comprehensive clinicopathologic studies including virologic and in vitro culture with inducing agents;Brody;Cancer,1995

3. A cutaneous agranular CD2− CD4+ CD56+ “lymphoma”: report of two cases and review of the literature;Kameoka;Am J Clin Pathol,1998

4. CD4+ CD56+ cutaneous neoplasms: a distinct hematological entity? Groupe Francais d’Etude des Lymphomes Cutanes (GFELC);Petrella;Am J Surg Pathol,1999

5. Agranular CD4+CD56+ blastic natural killer leukemia/lymphoma;Kimura;Ann Hematol,2001

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Superior migration ability of umbilical cord-derived mesenchymal stromal cells (MSCs) toward activated lymphocytes in comparison with those of bone marrow and adipose-derived MSCs;Frontiers in Cell and Developmental Biology;2024-03-11

2. TLR4 sensitizes plasmacytoid dendritic cells for antiviral response against SARS-CoV-2 coronavirus;Journal of Leukocyte Biology;2023-09-25

3. Leveraging a powerful allogeneic dendritic cell line towards neoantigen-based cancer vaccines;Genes & Cancer;2023-01-30

4. CRISPR/Cas9 and AAV mediated insertion of β2 microglobulin-HLA-G fusion gene protects mesenchymal stromal cells from allogeneic rejection and potentiates the use for off-the-shelf cell therapy;Regenerative Therapy;2022-12

5. A single‐cell surgery microfluidic device for transplanting tumor cytoplasm into dendritic cells without nuclei mixing;Biotechnology Journal;2022-11-29